94 filings
Page 3 of 5
8-K
dul7qind6p 9uv
23 Dec 19
Entry into a Material Definitive Agreement
12:00am
8-K
k1t6ue uc6
21 Nov 19
Emerald Bioscience Announces $2.0 Million Registered Direct Offering
5:21pm
8-K
n3z6m lm8ulxh5lnmzh
20 Nov 19
Submission of Matters to a Vote of Security Holders
6:03am
8-K
w7eyrum3v7lwd35d2wv
27 Aug 19
Entry into a Material Definitive Agreement
5:03pm
8-K
forbg5
23 Aug 19
Other Events
7:42am
8-K
8xg19 nfsnt
8 Aug 19
Entry into a Material Definitive Agreement
5:27pm
8-K
kb6nb aipwh
29 May 19
Emerald Bioscience Secures “All Fields” Licenses for Cannabinoid Derivatives Developed by University of Mississippi
4:53pm
8-K
561mro96mq 3v
1 Apr 19
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
6:38am
8-K
kzwq5p3dgtjbr q7
25 Mar 19
Inc. and Provides Update of Recent Research Accomplishments
4:15pm
8-K
8cm lxn015mshu
4 Mar 19
Nemus Bioscience Signs Agreement with Noramco to Manufacture Proprietary Cannabidiol Analog
4:53pm
8-K
d51zo99qwzjclu
1 Feb 19
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:43pm
8-K
3s3lu2gan
16 Nov 18
Amendments to Articles of Incorporation or Bylaws
8:56am
8-K
tysp b1dczfgmdiw1p59
6 Nov 18
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
7:08am
8-K
qfkuk56e1
12 Oct 18
Nemus Bioscience Announces that Emerald Health Sciences has Provided a Credit Facility of up to $20
6:03am
8-K
o3wb k2vrl0svv804m1
1 Aug 18
Entry into a Material Definitive Agreement
8:38am
8-K
zdmgk
1 Jun 18
Entry into a Material Definitive Agreement
12:50pm
8-K
tpbzsh
4 May 18
Departure of Directors or Certain Officers
5:01pm
8-K
g43bv64e9a6ckvf4z
20 Feb 18
Emerald Health, Strategic Majority Investor in Nemus Bioscience, Completes Final
12:00am
8-K
cnkua6
13 Feb 18
Regulation FD Disclosure
12:00am
8-K
0pv52tfi9
22 Jan 18
Nemus Secures Emerald Health as Strategic Majority Investor to help Advance Clinical Development of Novel Cannabinoid-based Therapeutics
12:00am